• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔鳞状细胞癌患者的组织和血清 microRNA 谱。

Tissue and serum microRNA profile of oral squamous cell carcinoma patients.

机构信息

Faculdade de Nutrição, Universidade Federal de Pelotas, Pelotas, RS, Brazil.

College of Medicine, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida, 32827, USA.

出版信息

Sci Rep. 2018 Jan 12;8(1):675. doi: 10.1038/s41598-017-18945-z.

DOI:10.1038/s41598-017-18945-z
PMID:29330429
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5766573/
Abstract

Head and neck cancer is characterized by malignant tumors arising from the epithelium covering the upper aerodigestive tract, and the majority of these epithelial malignancies are squamous cell carcinomas (SCCs) of the oral cavity (OSCCs). The aim of the current work was to identify miRNAs regulated in OSCC cancerous tissue when compared to a healthy adjacent tissue and to verify the presence of the same miRNAs in the circulation of these patients. For that serum samples and biopsies of healthy and tumor tissues were collected from five patients diagnosed with OSCC of the oral cavity, RNA was extracted from these samples and microRNAs libraries were prepared and sequenced. A total 255 miRNAs were identified in tissue and 381 different miRNAs were identified in serum samples. When comparing the miRNA expression between tumor and healthy tissue we identified 48 miRNAs (25 down- and 23 up-regulated) that were differentially expressed (FDR < 0.05). From these 48 differentially expressed miRNAs in tissue, 30 miRNAs were also found in the serum of the same patients. hsa-miR-32-5p was up-regulated in tumor compared to healthy tissue in our study, and was previously shown to be up-regulated in the serum of OSCC patients. Therefore, this suggests that miRNAs can be used as potential non-invasive biomarkers of OSCC.

摘要

头颈部癌症的特征是来源于覆盖上呼吸道的上皮组织的恶性肿瘤,这些上皮恶性肿瘤大多数为口腔的鳞状细胞癌(OSCC)。目前这项工作的目的是确定与健康相邻组织相比,口腔鳞状细胞癌癌组织中受调控的 miRNA,并验证这些患者的循环中是否存在相同的 miRNA。为此,从 5 名被诊断为口腔 OSCC 的患者中收集了血清样本和健康及肿瘤组织的活检,从这些样本中提取 RNA,并准备和测序 microRNA 文库。在组织中鉴定出了 255 种 miRNA,在血清样本中鉴定出了 381 种不同的 miRNA。当比较肿瘤和健康组织中的 miRNA 表达时,我们确定了 48 个 miRNA(25 个下调和 23 个上调)存在差异表达(FDR<0.05)。在组织中这 48 个差异表达的 miRNA 中,有 30 个也在同一患者的血清中被发现。在我们的研究中,hsa-miR-32-5p 在肿瘤中相对于健康组织上调,并且先前在 OSCC 患者的血清中显示上调。因此,这表明 miRNA 可以作为 OSCC 的潜在非侵入性生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f095/5766573/250f524e724c/41598_2017_18945_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f095/5766573/250f524e724c/41598_2017_18945_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f095/5766573/250f524e724c/41598_2017_18945_Fig1_HTML.jpg

相似文献

1
Tissue and serum microRNA profile of oral squamous cell carcinoma patients.口腔鳞状细胞癌患者的组织和血清 microRNA 谱。
Sci Rep. 2018 Jan 12;8(1):675. doi: 10.1038/s41598-017-18945-z.
2
Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.循环微小RNA作为口腔鳞状细胞癌手术患者复发的生物标志物
Oncotarget. 2017 Jan 31;8(5):8206-8214. doi: 10.18632/oncotarget.14143.
3
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.全基因组唾液 microRNA 研究鉴定 miR-423-5p 作为口腔鳞状细胞癌有前途的诊断和预后生物标志物。
Theranostics. 2021 Jan 1;11(6):2987-2999. doi: 10.7150/thno.45157. eCollection 2021.
4
Integrated Analysis and MicroRNA Expression Profiling Identified Seven miRNAs Associated With Progression of Oral Squamous Cell Carcinoma.综合分析和微小RNA表达谱鉴定出与口腔鳞状细胞癌进展相关的七种微小RNA。
J Cell Physiol. 2017 Aug;232(8):2178-2185. doi: 10.1002/jcp.25728. Epub 2017 Mar 1.
5
Novel non-invasive molecular signatures for oral cavity cancer, by whole transcriptome and small non-coding RNA sequencing analyses: Predicted association with PI3K/AKT/mTOR pathway.通过全转录组和小非编码 RNA 测序分析鉴定口腔癌新型无创分子标志物:与 PI3K/AKT/mTOR 通路的预测关联。
Cancer Med. 2024 Jun;13(11):e7309. doi: 10.1002/cam4.7309.
6
Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.口腔鳞状细胞癌:用于阐明肿瘤发生机制的微小RNA表达谱分析及综合分析
Mol Cancer. 2016 Apr 7;15:28. doi: 10.1186/s12943-016-0512-8.
7
Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.血清微小RNA-483-5p:口腔鳞状细胞癌患者一种新型的诊断和预后生物标志物。
Tumour Biol. 2016 Jan;37(1):447-53. doi: 10.1007/s13277-015-3514-z. Epub 2015 Jul 30.
8
MicroRNA-based classifiers for diagnosis of oral cavity squamous cell carcinoma in tissue and plasma.基于 microRNA 的口腔鳞状细胞癌组织和血浆诊断分类器。
Oral Oncol. 2018 Aug;83:46-52. doi: 10.1016/j.oraloncology.2018.05.020. Epub 2018 Jun 12.
9
Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma.循环微小RNA作为头颈部鳞状细胞癌的新型预后生物标志物
Cancer Biol Ther. 2015;16(7):1042-6. doi: 10.1080/15384047.2015.1045692. Epub 2015 May 7.
10
Integrated Bioinformatics Analysis of mRNAs and miRNAs Identified Potential Biomarkers of Oral Squamous Cell Carcinoma.mRNA和miRNA的综合生物信息学分析鉴定出口腔鳞状细胞癌的潜在生物标志物。
Asian Pac J Cancer Prev. 2020 Jun 29;21(6):1841-1848. doi: 10.31557/APJCP.2020.21.6.1841.

引用本文的文献

1
The microRNA-6510 as a potential tumor suppressor in head and neck cancer.微小RNA-6510作为头颈癌中一种潜在的肿瘤抑制因子。
Sci Rep. 2025 Feb 18;15(1):5830. doi: 10.1038/s41598-025-86796-0.
2
Patient-matched tumours, plasma, and cell lines reveal tumour microenvironment- and cell culture-specific microRNAs.患者匹配的肿瘤、血浆和细胞系揭示了肿瘤微环境和细胞培养特异性的微小RNA。
Biol Open. 2024 Dec 15;13(12). doi: 10.1242/bio.060483. Epub 2024 Dec 23.
3
Oral Squamous Cell Carcinoma: Focus on Biomarkers for Screening.口腔鳞状细胞癌:聚焦于筛查生物标志物

本文引用的文献

1
Is immunohistochemical evaluation of p16 in oropharyngeal cancer enough to predict the HPV positivity?对口咽癌进行p16的免疫组化评估足以预测人乳头瘤病毒(HPV)阳性吗?
Rep Pract Oncol Radiother. 2017 May-Jun;22(3):237-242. doi: 10.1016/j.rpor.2017.01.003. Epub 2017 Apr 22.
2
Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.循环微小RNA作为口腔鳞状细胞癌手术患者复发的生物标志物
Oncotarget. 2017 Jan 31;8(5):8206-8214. doi: 10.18632/oncotarget.14143.
3
Regulation of MMP13 by antitumor microRNA-375 markedly inhibits cancer cell migration and invasion in esophageal squamous cell carcinoma.
J Dent (Shiraz). 2024 Mar 1;25(1):1-16. doi: 10.30476/dentjods.2023.96159.1924. eCollection 2024 Mar.
4
Differential microRNA Expression Analysis in Patients with HPV-Infected Ovarian Neoplasms.HPV 感染性卵巢肿瘤患者差异 microRNA 表达分析。
Int J Mol Sci. 2024 Jan 7;25(2):762. doi: 10.3390/ijms25020762.
5
Identification of serum miR-1246 and miR-150-5p as novel diagnostic biomarkers for high-grade serous ovarian cancer.鉴定血清 miR-1246 和 miR-150-5p 作为高级别浆液性卵巢癌的新型诊断生物标志物。
Sci Rep. 2023 Nov 7;13(1):19287. doi: 10.1038/s41598-023-45317-7.
6
Serum and Saliva Level of miR-31-5p and miR-let 7a in EBV Associated Oropharyngeal Cancer.EBV 相关口咽癌中 miR-31-5p 和 miR-let 7a 的血清及唾液水平
Int J Mol Sci. 2023 Jul 26;24(15):11965. doi: 10.3390/ijms241511965.
7
Pharmacological impact of microRNAs in head and neck squamous cell carcinoma: Prevailing insights on molecular pathways, diagnosis, and nanomedicine treatment.微小RNA在头颈部鳞状细胞癌中的药理作用:关于分子途径、诊断及纳米医学治疗的当前见解
Front Pharmacol. 2023 May 3;14:1174330. doi: 10.3389/fphar.2023.1174330. eCollection 2023.
8
Evaluation of the Expression Levels of miR-21-5p and miR-429 Genes in Biopsy Samples from Patients with Oral Squamous Cell Carcinoma.口腔鳞状细胞癌患者活检样本中miR-21-5p和miR-429基因表达水平的评估
Diagnostics (Basel). 2023 Mar 25;13(7):1244. doi: 10.3390/diagnostics13071244.
9
Circulating miRNA as a Biomarker in Oral Cancer Liquid Biopsy.循环微RNA作为口腔癌液体活检中的生物标志物
Biomedicines. 2023 Mar 21;11(3):965. doi: 10.3390/biomedicines11030965.
10
Salivary protein kinase C alpha and novel microRNAs as diagnostic and therapeutic resistance markers for oral squamous cell carcinoma in Indian cohorts.唾液蛋白激酶Cα和新型微小RNA作为印度人群口腔鳞状细胞癌的诊断和治疗耐药性标志物
Front Mol Biosci. 2023 Jan 10;9:1106963. doi: 10.3389/fmolb.2022.1106963. eCollection 2022.
抗肿瘤微小RNA-375对基质金属蛋白酶13的调控显著抑制食管鳞状细胞癌的癌细胞迁移和侵袭。
Int J Oncol. 2016 Dec;49(6):2255-2264. doi: 10.3892/ijo.2016.3745. Epub 2016 Oct 21.
4
miR-31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma.微小RNA-31靶向ARID1A并增强头颈部鳞状细胞癌的致癌性和干性。
Oncotarget. 2016 Aug 30;7(35):57254-57267. doi: 10.18632/oncotarget.11138.
5
Serum-based microRNA signatures in early diagnosis and prognosis prediction of colon cancer.基于血清的微小RNA特征在结肠癌早期诊断和预后预测中的应用
Carcinogenesis. 2016 Oct;37(10):941-950. doi: 10.1093/carcin/bgw078. Epub 2016 Aug 1.
6
Expression profiles of miR-29c, miR-200b and miR-375 in tumour and tumour-adjacent tissues of head and neck cancers.miR-29c、miR-200b和miR-375在头颈癌肿瘤组织及癌旁组织中的表达谱
Tumour Biol. 2016 Sep;37(9):12627-12633. doi: 10.1007/s13277-016-5147-2. Epub 2016 Jul 20.
7
PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.miR-21对PIK3R1的靶向作用通过降低PI3K/AKT信号传导和逆转上皮-间质转化来抑制肿瘤细胞迁移和侵袭,并可预测乳腺癌的临床结局。
Int J Oncol. 2016 Feb;48(2):471-84. doi: 10.3892/ijo.2015.3287. Epub 2015 Dec 10.
8
Effect of radiotherapy delay in overall treatment time on local control and survival in head and neck cancer: Review of the literature.头颈部癌总体治疗时间中放疗延迟对局部控制和生存的影响:文献综述
Rep Pract Oncol Radiother. 2015 Sep-Oct;20(5):328-39. doi: 10.1016/j.rpor.2015.05.010. Epub 2015 Jul 4.
9
Unpredictable changes of selected miRNA in expression profile of HNSCC.头颈部鳞状细胞癌表达谱中选定 miRNA 表达的不可预测变化。
Cancer Biomark. 2016;16(1):55-64. doi: 10.3233/CBM-150540.
10
KEGG as a reference resource for gene and protein annotation.KEGG作为基因和蛋白质注释的参考资源。
Nucleic Acids Res. 2016 Jan 4;44(D1):D457-62. doi: 10.1093/nar/gkv1070. Epub 2015 Oct 17.